|1.||van Schaardenburg, Dirkjan: 12 articles (12/2015 - 01/2010)|
|2.||Mao, Jun J: 10 articles (08/2015 - 08/2009)|
|3.||DeMichele, Angela: 8 articles (01/2015 - 06/2009)|
|4.||McDougall, Jason J: 8 articles (01/2014 - 05/2006)|
|5.||Ng, Lisa F P: 6 articles (08/2015 - 01/2011)|
|6.||Hershman, Dawn L: 6 articles (06/2015 - 09/2007)|
|7.||Huizinga, Tom W J: 6 articles (01/2015 - 04/2013)|
|8.||Farrar, John T: 6 articles (12/2014 - 06/2009)|
|9.||van de Stadt, Lotte A: 5 articles (01/2015 - 01/2010)|
|10.||Xie, Sharon X: 5 articles (12/2014 - 06/2009)|
|1.||Prednisolone (Predate)FDA LinkGeneric
11/01/2015 - "Although the joint pain improved with low-dose prednisolone administration, she was referred to our department in April of 2014 because she had become aware of swelling of the right cervical lymph node. "
06/01/2012 - "Joint pain symptoms improved in 67% of patients immediately after prednisolone use, with 63% still reporting analgesic effect at one month, and 52% at two months after beginning internal use of prednisolone. "
03/01/1998 - "Immunosuppressive therapy with prednisolone (PSL) for acute GVHD was given, and the arthralgia improved rapidly, correlating with the improvement in dermal and hepatic GVHD. "
02/01/2012 - "Severe side effects of myalgia and arthralgia would have necessitated a treatment interruption, but a trial of prednisolone gave excellent symptomatic relief. "
01/01/2015 - "After the discontinuation of prednisolone he developed swelling of the eyelids and polyarthralgia. "
|2.||Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA
02/01/1985 - "Both nonsteroidal anti-inflammatory agents showed statistically significant improvement in efficacy variables including duration of morning stiffness, disease activity as judged by the examiner and by the patient, patient assessment of feeling, total joint pain, total joint swelling, and performance of daily activities. "
08/01/1993 - "Unquestionably, use of NSAIDs has reduced joint pain and improved mobility for millions of patients with OA. "
07/01/2011 - "A total of 313 undiagnosed subjects, who first visited Keio University Hospital with joint symptoms, including arthralgia, joint swelling and morning stiffness, without any previous treatment except for NSAIDs, were included in the present study. "
02/01/2009 - "However, NSAIDS may be required for relief of severe arthralgia during convalescent phase."
05/01/2008 - "One of the most common comorbid conditions is joint pain requiring the use of non-steroidal anti-inflammatory medications (NSAIDs). "
10/01/1998 - "Among completers (54 and 34 patients, respectively), significant improvement compared to baseline was noted in all seven clinical variables (morning stiffness, overall joint pain, count of tender/swollen joints, Lansbury articular score, functional score and grip strength), ESR and C-reactive protein without significant intergroup differences. "
01/01/2000 - "Statistically significant differences were found only for arthralgia (P=0.026) and elevated concentration of C-reactive protein (P=0.003); both variables were found more often in patients with acute HGE. "
10/01/2011 - "After one year's treatment with the S-15 column, the β2-m level decreased from 29.3±9.6mg/L to 24.7±5.1mg/L (P<0.05), and the high sensitive C-reactive protein level decreased from 2996±4380ng/mL to 1292±1774ng/mL. After one year of S-15 column use, pinch strength increased from 5.9±3.0pounds to 7.2±3.2pounds (P<0.05), and the visual analog scale for joint pain and activities of daily living score also improved. "
01/01/2015 - "Standard data collected included demographic data, erythrocyte sedimentation rate, C-reactive protein, clinical measures of disease activity (Disease Activity Score in 28 joint counts [DAS28], Clinical Disease Activity Index [CDAI], Simplified Disease Activity Index [SDAI] and global assessments) and patient-reported outcomes (measures of physical function, joint pain, fatigue, patient global assessment and morning stiffness). "
01/01/2014 - "Among the ACPA-negative arthralgia patients, MRI inflammation scores were related to C-reactive protein (CRP) levels and the tenderness of scanned joints. "
12/01/1986 - "The arthralgia has responded slowly to the administration of anti-inflammatory drugs and steroids. "
08/01/1997 - "Patients experiencing bone or joint pains while receiving high dose steroids as part of a chemotherapy regimen could be investigated by bone scintigraphy but MRI is preferable as it is more sensitive and specific for AVN. "
07/01/2005 - "Occurrence of arthralgias and/or myalgias did not appear to be influenced by respondent age, course length, concurrent use of oral steroids, or a history of arthritis. "
03/01/2004 - "Our two patients exhibited arthritis and/or arthralgia, purpuric skin lesions, abdominal pain and hemiaturia, and were treated with steroids. "
01/01/1976 - "Our patient and those of Agnello et al. had identical clinical symptoms such as erythema multiforme, arthralgias and angioneurotic edema and both differed from systemic lupus erthematosus in several important points, i.e., in spite of marked hypocomplementemia the nephropathy is not prominent and it needs high-dose steroids to eliminate the clinical and serological abnormalities. "
|5.||Analgesics (Analgesic Drugs)IBA
11/01/2013 - "A broader understanding of the pathological mechanisms driving OA joint pain is vital for the development of improved analgesics. "
05/01/2007 - "Follow-up demonstrated slow improvement in joint pain and stiffness despite symptomatic treatment, mainly antiinflammatory and analgesic drugs. "
02/01/2013 - "The aim is to identify what factors are associated with primary care prescribing of high-strength analgesics in a community sample of older people with joint pain. "
01/01/2013 - "The proportion of those patients suffering from joint pain and using prescribed analgesics for that was 35.5% in 1999 and 41.5% in 2009 (p < 0.001). "
05/01/2012 - "Bone and joint pains were other problems that led to the use of analgesics. "
|6.||Hyaluronic Acid (Hyaluronan)IBA
01/01/2011 - "Evaluation of long-term antinociceptive properties of stabilized hyaluronic acid preparation (NASHA) in an animal model of repetitive joint pain."
11/01/1993 - "Effects of the molecular weight of hyaluronic acid and its action mechanisms on experimental joint pain in rats."
01/01/2010 - "Hyaluronan (HA) has been proven to be effective in relieving joint pain and improving function in chronic osteoarthritis. "
01/01/2013 - "The aim of this study to evaluate the efficacy of intra-articular hyaluronic acid in patients with knee osteoarthritis with regard to joint pain and function, as well as patient satisfaction, assessed at one month and at one year, and by age group. "
08/01/2015 - "Hyaluronic acid (HA), a natural biomaterial present in healthy joints but depleted in osteoarthritis (OA), has been employed clinically to provide symptomatic relief of joint pain. "
05/01/1998 - "Limited data from short-term human trials suggest that glucosamine sulfate administered orally, intravenously, intramuscularly, and intraarticularly may produce a gradual and progressive reduction in joint pain and tenderness, as well as improved range of motion and walking speed. "
07/15/2007 - "The symptomatic improvement of joint pain at walking, at rest and stiffness after 6 week treatment with glucosamine hydrochloride was better than those with glucosamine sulfate. "
01/29/2007 - "A 3 months', post-marketing, randomised, double-blinded, placebo-controlled, clinical trial was performed with parallel groups of 66 patients over 40 years of age with joint pain of long duration receiving either recommend dosage (1500 mg per day) of glucosamine sulphate or placebo. "
03/01/2002 - "The conclusion is that glucosamine is effective in relieving joint pain associated with osteoarthritis. "
04/01/2013 - "We conducted a single-arm, open-label, phase II study evaluating glucosamine-sulfate (1,500 mg/day) + chondroitin-sulfate (1,200 mg/day) for 24 weeks to treat joint pain/stiffness in postmenopausal women with early stage breast cancer who developed moderate-to-severe joint pain after initiating AIs. "
|8.||Botulinum Toxins (Botulinum Toxin)IBA
05/01/2010 - "Botulinum toxin (BT) type A has been shown to provide significant reduction of joint pain, and functional improvements. "
04/01/2014 - "The aim of this study was to investigate the efficacy of intra-articular (IA) botulinum toxin A (IA BoNT A) for the treatment of osteoarthritic joint pain in dogs. "
04/01/2014 - "Intra-articular botulinum toxin A for the treatment of osteoarthritic joint pain in dogs: a randomized, double-blinded, placebo-controlled clinical trial."
04/01/2006 - "Long term effects of intra-articular botulinum toxin A for refractory joint pain."
03/01/2009 - "Intra-articular botulinum toxin A as an adjunctive therapy for refractory joint pain in patients with rheumatoid arthritis receiving biologics: a report of two cases."
|9.||Prednisone (Sone)FDA LinkGeneric
11/01/2015 - "Patient-reported joint pain (β=-0.155, p=0.046), BDQoL (β=0.176, p=0.032), and BDI (β=0.017, p<0.0001) scores, suicidal thoughts before the onset of BS (β=-0.124, p=0.043), neurologic involvement (β=0.119, p=0.047) and past prednisone use (β=0.212, p=0.005) were independent predictors of suicidal thoughts. "
02/01/2014 - "At the onset of therapy, despite the use of prednisone (27.6 ± 26.3 mg/d), all patients reported joint pain. "
01/01/2002 - "The patient was also on prednisone and a nonsteroidal anti-inflammatory drug for joint pains. "
03/01/2000 - "MTX was discontinued; several weeks later prednisone 10 mg/day was added to control worsening polyarthralgia. "
09/30/1993 - "The patient was treated with prednisone for six months, and after one year of observation the mass has disappeared, but the arthralgias persists."
|10.||TNFR-Fc fusion protein (etanercept)FDA Link
07/01/2011 - "All clinical measures of disease severity, including joint tenderness/pain, joint swelling, and Psoriasis Area and Severity Index score, improved significantly between baseline and Month 6 of etanercept treatment and remained constant thereafter. "
08/01/2009 - "Sustained improvement in joint pain and nail symptoms with etanercept therapy in patients with moderate-to-severe psoriasis."
01/01/2014 - "Female, 51 FINAL DIAGNOSIS: Interstitial Granulomatous Dermatitis Symptoms: Joint pain • pruritic rush Etanercept Clinical Procedure: - Specialty: Rheumatology. "
01/01/2013 - "After informed consent, etanercept was initiated and resulted in complete remission of aphthous stomatitis, decrease in arthralgia and fatigue and considerable improvement in her quality of life. "
10/15/2007 - "A 70-year-old patient with long-standing psoriatic arthritis developed pleuritis, pericarditis, as well as marked arthralgias during therapy with etanercept. "
07/01/2007 - "Significant improvement of clinical symptoms, including the joint swelling index, joint tenderness index, joint pain index, time of morning stiffness and VAS revealed in both groups after treatment, and the effect in the treatment group was better (P<0.05 or P<0.01). "
03/01/2012 - "The scores of joint pain, morning stiffness, joint swelling and walking ability after treatment were all apparently improved as compared with those before treatment in either group (all P < 0.05). "
01/01/2015 - "SI joint pain scores, Oswestry Disability Index (ODI), Short-Form 36 (SF-36) and EuroQol-5D (EQ-5D) were collected at baseline and at 1, 3 and 6 months after treatment commencement. "
11/01/2014 - "Joint pain, mandibular activity, facial symmetry after treatment, and jaw development impact should not be used as the influencing factors for treatment methods selection."
11/01/2014 - "Surgical treatment has significant advantages in improving the maximal mouth opening as well as the occlusional relationship and has no significant statistical difference in the occurrence of joint pain after treatment, facial symmetry, and mandibular activity status in the 2 groups. "
|2.||Drug Therapy (Chemotherapy)
09/01/2014 - "Findings indicate that the patients' perception of sudden onset of chemotherapy-related muscle and joint pain was not aggravated by training. "
04/15/2012 - "In particular, bone loss and arthralgias are prevalent side effects experienced by women treated with chemotherapy and/or adjuvant endocrine therapy. "
11/01/2002 - "After effective chemotherapy, he complained of arthralgia and a bone scintigram showed abnormal uptakes in his bilateral shoulder, knee and wrist. "
08/01/1994 - "Decreasing joint pain often is the first sign of a clinical response to chemotherapy. "
09/01/2010 - "In patients with injection-confirmed zygapophysial joint pain, procedural interventions can be undertaken in the context of a multidisciplinary, multimodal treatment regimen that includes pharmacotherapy, physical therapy and regular exercise, and, if indicated, psychotherapy. "
07/01/2012 - "This study demonstrates that one single intra-articular injection of non-cross-linked HA reduces joint pain and increases function in patients with KOA over a period of at least 6 months."
05/01/2012 - "She reported no medical history, except for intraarticular injection of a corticosteroid for joint pain for the duration of two months. "
09/01/2008 - "Finally, the effect of an intra-articular injection of Na(2)S on joint pain in control and inflamed rats was determined by hindlimb incapacitance and von Frey hair algesiometry. "
12/01/2007 - "Intra-articular injections are one method that physicians may use to treat joint pain. "
03/01/2007 - "Intra-articular injections are one method that physicians may use to treat joint pain. "
|4.||Activities of Daily Living (ADL)
08/01/2001 - "Patients had a more significant improvement in hand pain, joint tenderness, and ADL score (P < 0.005) than in range of motion (P < 0.01). "
10/01/2011 - "During the study period, pinch strength, visual analog scale for joint pain, and activities of daily living were evaluated every three months, and blood sampling was performed every six months. "
02/01/2016 - "Joint pain and joint stiffness were reported by 61.6 and 59.1 % of patients, respectively, although these symptoms did not affect the activities of daily living in 96.0 and 97.9 % of patients, respectively. "
01/01/2013 - "A prospective cohort study of older adults (≥65 years) with joint pain and comorbidity provided baseline data (n = 407) consisting of PF (PF subscale, RAND-36; 10 items), ADL (KATZ index; 6 items), IADL (Lawton index; 7 items) and participation (KAP; 6 items). "
01/01/2012 - "The diagnosis is based on a history of joint pain worsened by movement, which can lead to disability in activities of daily living. "
06/01/1993 - "The results of this study indicated that (1) the treatment result of joint and muscle pain, joint sounds, limitation of mouth opening and jaw deviation after conservative treatment showed statistically significant improvement; and (2) this study was unable to demonstrate any influence of sex, age or duration of the splint use on the treatment effect. "
07/01/2004 - "The authors treated 40 patients (average age 16.8; range 8.0-24.0) with confirmed internal derangement, joint pain, and joint noises in at least one TMJ for at least two months, with AR splint (20 subjects) or FAMS splint (20 subjects); 10 untreated patients comprised the control group. "
07/01/2004 - "Treatment of joint pain and joint noises associated with a recent TMJ internal derangement: a comparison of an anterior repositioning splint, a full-arch maxillary stabilization splint, and an untreated control group."
05/01/1998 - "[Short-term effects of the Michigan splint on muscular and joint pain]."
08/01/1985 - "The anterior repositioning splint decreased joint pain at rest, during chewing, and during protrusion. "